(Total Views: 620)
Posted On: 04/19/2020 9:16:46 AM
Post# of 153903
Question Time.
I’m relatively new to trading/investing and CYDY is the one stock I’ve held on to and spent many hours tracking and researching. It’s always felt like NP was trying to position the company to be sold, spending very little resources in each potential indication (besides HIV) to get just enough proof of concept to make the company as valuable in a buyout as possible. But now I wonder if coronavirus has propelled the company’s intellectual property (or will have very soon) to a place where a buyout becomes too expensive. Now that it’s added to HIV and promising early results in cancer, GVHD, etc. I don’t know how to figure such things out, or do the math, but I know a lot of you can and do.
So I guess it’s two questions I’m interested in everybody’s thoughts on.
1) Are we past the point (or will we be in the next few weeks/months) of a buyout due to how high the cost would need to be? I think about this a lot and have no clue how to gauge it.
2) I don’t know if my amount of shares would even factor in to accepting or rejecting a buyout offer should one come (I only have around 37,000 shares and I honestly don’t know how any of that works. My guess is they wouldn’t matter) but if I did need to vote and the votes actually mattered I’d be looking to everyone here for a consensus about whether it’s a good or bad offer. Is there a simple(ish) way to calculate what a good or decent offer is? I don’t want to be the guy who pushes a bad deal over the finish line by 1, lol.
Thanks for humoring my ignorance and thanks for all the good posts. I really enjoy reading everything here each day, especially as news breaks.
I’m relatively new to trading/investing and CYDY is the one stock I’ve held on to and spent many hours tracking and researching. It’s always felt like NP was trying to position the company to be sold, spending very little resources in each potential indication (besides HIV) to get just enough proof of concept to make the company as valuable in a buyout as possible. But now I wonder if coronavirus has propelled the company’s intellectual property (or will have very soon) to a place where a buyout becomes too expensive. Now that it’s added to HIV and promising early results in cancer, GVHD, etc. I don’t know how to figure such things out, or do the math, but I know a lot of you can and do.
So I guess it’s two questions I’m interested in everybody’s thoughts on.
1) Are we past the point (or will we be in the next few weeks/months) of a buyout due to how high the cost would need to be? I think about this a lot and have no clue how to gauge it.
2) I don’t know if my amount of shares would even factor in to accepting or rejecting a buyout offer should one come (I only have around 37,000 shares and I honestly don’t know how any of that works. My guess is they wouldn’t matter) but if I did need to vote and the votes actually mattered I’d be looking to everyone here for a consensus about whether it’s a good or bad offer. Is there a simple(ish) way to calculate what a good or decent offer is? I don’t want to be the guy who pushes a bad deal over the finish line by 1, lol.
Thanks for humoring my ignorance and thanks for all the good posts. I really enjoy reading everything here each day, especially as news breaks.
(4)
(0)
